Heat Biologics, Inc.

Recent News View All News

Heat Biologics Completes Name Change to NightHawk Biosciences; Trading to Commence Under “NHWK” Effective at the Market Open Today

May 3, 2022

Heat Biologics (NightHawk Biosciences) Announces that its Elusys Therapeutics Subsidiary has Executed a Contract to Deliver ANTHIM® to the Canadian Government

April 27, 2022

Recent Events View IR Calendar

Investor and Media Livestream

Apr 19, 2022 • 10:30am EDT

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings